Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: Role of fibroblast growth factor receptor-2

Cancer Research

Volumn 66, Issue 23, 2006, Pages 11271-11278

  Chaffer, Christine L ^a,b   Brennan, Janelle P ^a,b   Slavin, John L ^a   Blick, Tony ^c   Thompson, Erik W ^a,b,c   Williams, Elizabeth D ^a,b,d,e  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e MONASH MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 2 IIIC; FIBROBLAST GROWTH FACTOR RECEPTOR 3; FIBROBLAST GROWTH FACTOR RECEPTOR 4; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CANCER; CANCER GROWTH; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MESENCHYME CELL; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSITIONAL CELL CARCINOMA;

ANIMALS; BLOTTING, WESTERN; CARCINOMA, TRANSITIONAL CELL; CELL DIFFERENTIATION; CELL LINE, TUMOR; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KERATINS; MESODERM; MICE; NEOPLASM METASTASIS; NEOPLASMS, EXPERIMENTAL; PROTEIN ISOFORMS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL ANALYSIS; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS; URINARY BLADDER NEOPLASMS; VIMENTIN;

EID: 33845809125     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-2044     Document Type: Article

References (44)

1. Fidler IJ. Critical determinants of metastasis. Semin Cancer Biol 2002;12:89-96.
2. Hay ED. The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it Dev Dyn 2005;233:706-20.
3. Prindull G, Zipori D. Environmental guidance of normal and tumor cell plasticity: epithelial mesenchymal transitions as a paradigm. Blood 2004;103:2892-9.
4. Shook D, Keller R. Mechanisms, mechanics and function of epithelial-mesenchymal transitions in early development. Mech Dev 2003;120:1351-83.
5. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002;2:442-54.
6. Kim K, Lu Z, Hay ED. Direct evidence for a role of β-catenin/LEF-1 signaling pathway in induction of EMT. Cell Biol Int 2002;26:463-76.
7. Brabletz T, Jung A, Spaderna S, et al. Opinion: migrating cancer stem cells-an integrated concept of malignant tumour progression. Nat Rev Cancer 2005;5:744-9.
8. Christ B, Ordahl CP. Early stages of chick somite development. Anat Embryol (Berl) 1995;191:381-96.
9. Vainio S, Lin Y. Coordinating early kidney development: lessons from gene targeting. Nat Rev Genet 2002;3:533-43.
10. Thomas JC, DeMarco RT, Pope JC. Molecular biology of ureteral bud and trigonal development. Curr Urol Rep 2003;6:146-51.
11. Ornitz DM, Xu J, Colvin JS, et al. Receptor specificity of the fibroblast growth factor family. J Biol Chem 1996;271:15292-7.
12. Zhang X, Ibrahimi OA, Olsen SK, et al. Receptor specificity of the fibroblast growth factor family, part II. J Biol Chem 2006;281:15694-700.
13. Cancilla B, Ford-Perriss MD, Bertram JF. Expression and localization of fibroblast growth factors and fibroblast growth factor receptors in the developing rat kidney. Kidney Int 1999;56:2025-39.
14. Perantoni AO, Dove LF, Karavanova I. Basic fibroblast growth factor can mediate the early inductive events in renal development. Proc Natl Acad Sci U S A 1995;92:4696-700.
15. Qiao J, Uzzo R, Obara-Ishihara T, et al. FGF-7 modulates ureteric bud growth and nephron number in the developing kidney. Development 1999;126:547-54.
16. Mansour SL, Goddard JM, Capecchi MR. Mice homozygous for a targeted disruption of the protooncogene int-2 have developmental defects in the tail and inner ear. Development 1993;117:13-28.
17. Partanen J, Makela TP, Eerola E, et al. FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern. EMBO J 1991;10:1347-54.
18. Hebert JM, Rosenquist T, Gotz J, et al. FGF5 as a regulator of the hair growth cycle: evidence from targeted and spontaneous mutations. Cell 1994;78:1017-25.
19. Ortega S, Ittmann M, Tsang SH, et al. Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2. Proc Natl Acad Sci U S A 1998;95:5672-7.
20. Celli G, LaRochelle WJ, Mackem S, et al. Soluble dominant-negative receptor uncovers essential roles for fibroblast growth factors in multi-organ induction and patterning. EMBO J 1998;17:1642-55.
21. Grisaru S, Cano-Gauci D, Tee J, et al. Glypican-3 modulates BMP- and FGF-mediated effects during renal branching morphogenesis. Dev Biol 2001;231:31-46.
22. Cano-Gauci DF, Song HH, Yang H, et al. Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome. J Cell Biol 1999;146:255-64.
23. Chaffer CL, Dopheide B, McCulloch DR, et al. Upregulated MT1-MMP/TIMP-2 axis in the TSU-Pr1-1/B2 model of metastatic progression in transitional cell carcinoma of the bladder. Clin Exp Metastasis 2005;22:115-25.
24. Djakiew D, Pflug BR, Delsite R, et al. Chemotaxis and chemokinesis of human prostate tumor cell lines in response to human prostate stromal cell secretory proteins containing a nerve growth factor-like protein. Cancer Res 1993;53:1416-20.
25. Sharp JA, Waltham M, Williams ED, et al. Transfection of MDA-MB-231 human breast carcinoma cells with bone sialoprotein (BSP) stimulates migration and invasion in vitro and growth of primary and secondary tumors in nude mice. Clin Exp Metastasis 2004;21:19-29.
26. McCulloch DR, Opeskin K, Thompson EW, et al. BM18: A novel androgen-dependent human prostate cancer xenograft model derived from a bone metastasis. Prostate 2005;65:35-43.
27. Price JT, Thompson EW. Models for studying cellular invasion of basement membranes. Methods Mol Biol 1999;129:231-49.
28. Udabage L, Brownlee GR, Waltham M, et al. Antisense-mediated suppression of hyaluronan synthase 2 inhibits the tumorigenesis and progression of breast cancer. Cancer Res 2005;65:6139-50.
29. Thiery JP, Sleeman JP. Complex networks orchestrate epithelial- mesenchymal transitions. Nat Rev Mol Cell Biol 2006;7:131-42.
30. Zi X, Guo Y, Simoneau AR, et al. Expression of Frzb/secreted Frizzled-related protein 3, a secreted Wnt antagonist, in human androgen-independent prostate cancer PC-3 cells suppresses tumor growth and cellular invasiveness. Cancer Res 2005;65:9762-70.
31. Lee JM, Dedhar S, Kalluri R, et al. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 2006;172:973-81.
32. Brabletz T, Hlubek F, Spaderna S, et al. Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and β-catenin. Cells Tissues Organs 2005;179:56-65.
33. Auersperg N, Pan J, Grove BD, et al. E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium. Proc Natl Acad Sci U S A 1999;96:6249-54.
34. De Medina SG, Popov Z, Chopin DK, et al. Relationship between E-cadherin and fibroblast growth factor receptor 2b expression in bladder carcinomas. Oncogene 1999;18:5722-6.
35. Billottet C, Janji B, Thiery JP, et al. Rapid tumor development and potent vascularization are independent events in carcinoma producing FGF-1 or FGF-2. Oncogene 2002;21:8128-39.
36. Miyake H, Yoshimura K, Hara I, et al. Basic fibroblast growth factor regulates matrix metalloproteinases production and in vitro invasiveness in human bladder cancer cell lines. J Urol 1997;157:2351-5.
37. Orr-Urtreger A, Bedford MT, Burakova T, et al. Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2). Dev Biol 1993;158:475-86.
38. Chellaiah AT, McEwen DG, Werner S, et al. Fibroblast growth factor receptor (FGFR) 3. Alternative splicing in immunoglobulin-like domain III creates a receptor highly specific for acidic FGF/FGF-1. J Biol Chem 1994;269:11620-7.
39. Alizadeh M, Miyamura N, Handa JT, et al. Human RPE cells express the FGFR2IIIc and FGFR3IIIc splice variants and FGF9 as a potential high affinity ligand. Exp Eye Res 2003;76:249-56.
40. Drugan CS, Paterson IC, Prime SS. Fibroblast growth factor receptor expression reflects cellular differentiation in human oral squamous carcinoma cell lines. Carcinogenesis 1998;19:1153-6.
41. Kwabi-Addo B, Ropiquet F, Giri D, et al. Alternative splicing of fibroblast growth factor receptors in human prostate cancer. Prostate 2001;46:163-72.
42. Valve E, Martikainen P, Seppanen J, et al. Expression of fibroblast growth factor (FGF)-8 isoforms and FGF receptors in human ovarian tumors. Int J Cancer 2000;88:718-25.
43. Steele IA, Edmondson RJ, Bulmer JN, et al. Induction of FGF receptor 2-IIIb expression and response to its ligands in epithelial ovarian cancer. Oncogene 2001;20:5878-87.
44. Wong CW, Song C, Grimes MM, et al. Intravascular location of breast cancer cells after spontaneous metastasis to the lung. Am J Pathol 2002;161:749-53.